Compare NWPX & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NWPX | ARDX |
|---|---|---|
| Founded | 1966 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 996.8M |
| IPO Year | 1996 | 2014 |
| Metric | NWPX | ARDX |
|---|---|---|
| Price | $110.59 | $15.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $70.00 | $15.14 |
| AVG Volume (30 Days) | 162.6K | ★ 4.7M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.71 | N/A |
| EPS | ★ 2.69 | N/A |
| Revenue | ★ $526,003,000.00 | $2,607,000.00 |
| Revenue This Year | $6.98 | $37.75 |
| Revenue Next Year | $3.30 | $34.24 |
| P/E Ratio | $41.08 | ★ N/A |
| Revenue Growth | ★ 6.79 | N/A |
| 52 Week Low | $49.45 | $3.73 |
| 52 Week High | $152.03 | $8.40 |
| Indicator | NWPX | ARDX |
|---|---|---|
| Relative Strength Index (RSI) | 39.29 | 25.38 |
| Support Level | $111.21 | N/A |
| Resistance Level | $114.27 | $6.47 |
| Average True Range (ATR) | 4.43 | 0.17 |
| MACD | -0.17 | -0.01 |
| Stochastic Oscillator | 27.06 | 3.14 |
NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products, and operates in two segments, Water Transmission Systems (WTS), operating as the Northwest Pipe Company brand, and Precast Infrastructure and Engineered Systems (Precast), which includes the brands NWPX Geneva and NWPX Park. WTS manufactures large-diameter, high-pressure steel pipeline systems for use in water infrastructure applications, which are related to drinking water systems. Precast manufactures stormwater and wastewater technology products, high-quality precast and reinforced concrete products, including reinforced concrete pipe (RCP), manholes, box culverts, vaults, and catch basins, pump lift stations, oil water separators, biofiltration units, and other environmental and engineered solutions.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.